A new obesity drug approved! Read on. . .

The FDA approved an obesity drug despite concerns that it might increase the risk of heart valve problems.  This release is in response to more than 1/3 of Americans are considered obese (a BMI of at least 30).  This drug, lorcaserin hydrochloride (Belviq) is a scheduled drug meaning no more than a 30 day prescription.  Patients taking lorcaserin for up to a year had an average weight loss of 3.7%.  This drug is not allowed during pregnancy.  Side effects may include problems with thinking, confusion, sleepiness, and in higher doses, hallucinations, euphoria or dissociation.

Consider weight loss and exercise.  Side effects and risks are better.

Advertisements

About drlesliegreenberg

I have been practicing as a family physician for over 20 years--as both an educator of physicians and clinician. From infancy to the elderly, I perform obstetrics and general medicine. I love my career and am passionate about my field of knowledge and my patients. Follow me on Facebook at Leslie Md Greenberg Medical Disclaimer The content of this website is provided for general informational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice. Do not use the information on this website for diagnosing or treating any medical or health condition. If you have or suspect you have a medical problem, promptly contact your professional healthcare provider.
This entry was posted in Uncategorized. Bookmark the permalink.